Literature DB >> 11543905

Genetic variability, molecular evolution, and geographic diversity of HLA-B27.

M A Blanco-Gelaz1, A López-Vázquez, S García-Fernández, J Martínez-Borra, S González, C López-Larrea.   

Abstract

HLA-B27 represents a family of 23 closely related alleles (B*2701-23) that differ at 24 amino acid positions. The pattern of polymorphisms of B27 was studied, with special reference to synonymous (Ks) and nonsynonymous (Ka) divergence among alleles. B27 alleles are characterized by the enhanced rate of nonsynonymous nucleotide substitution in the peptide-binding region (PBR). The percentage of substitutions between each of the B27 pairs ranges from 0.2%-3% in exons 2-3 to 1.8%-20.1% in the PBR. A phylogenetic analysis of all B27 alleles is described in order to identify subtypes with a common evolutionary history. These results, together with the phylogenetic trees obtained from the comparison between exons 2-3 and PBR indicate that polymorphism of B27 is selectively maintained. Most of the differences are clustered in the C/F pocket affecting the specific binding of antigenic peptides. Gene conversion and point mutation are the most important mechanisms responsible for B27 diversification. The interaction of selection, genetic drift, and recombination events is important for generating polymorphism at B27 alleles. We analyzed a large extended B27 positive population from different parts of the world. Our results indicate that B27 subtypes differ in their ethnic distribution, which may be the result of different genetic and geographical origins. Different factors such as genetic drift, bottleneck effect, and admixture among populations could contribute to the genetic constitution of B27. The striking correlation between the structural features of B27 and the ethnic distribution of these subtypes suggests a model of strong directional evolution, in which the subtypes could have arisen from B*2705.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11543905     DOI: 10.1016/s0198-8859(01)00299-3

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  11 in total

1.  The association of HLA-B*27 subtypes with ankylosing spondylitis in Wuhan population of China.

Authors:  Xiang Liu; Li-Hua Hu; Yi-Rong Li; Feng-Hua Chen; Yong Ning; Qun-Feng Yao
Journal:  Rheumatol Int       Date:  2009-06-18       Impact factor: 2.631

2.  Characterization of a proteasome and TAP-independent presentation of intracellular epitopes by HLA-B27 molecules.

Authors:  Adriana Magnacca; Irene Persiconi; Elisa Nurzia; Silvana Caristi; Francesca Meloni; Vincenzo Barnaba; Fabiana Paladini; Domenico Raimondo; Maria Teresa Fiorillo; Rosa Sorrentino
Journal:  J Biol Chem       Date:  2012-07-17       Impact factor: 5.157

Review 3.  Review for Disease of the Year: Epidemiology of HLA-B27 Associated Ocular Disorders.

Authors:  Laura J Kopplin; George Mount; Eric B Suhler
Journal:  Ocul Immunol Inflamm       Date:  2016-05-27       Impact factor: 3.070

4.  Reciprocal and nonreciprocal recombination at the glucocerebrosidase gene region: implications for complexity in Gaucher disease.

Authors:  Nahid Tayebi; Barbara K Stubblefield; Joseph K Park; Eduard Orvisky; Jamie M Walker; Mary E LaMarca; Ellen Sidransky
Journal:  Am J Hum Genet       Date:  2003-02-13       Impact factor: 11.025

5.  Clinical features of ankylosing spondylitis may correlate with HLA-B27 polymorphism.

Authors:  Zhen Wu; Zhiming Lin; Qiujing Wei; Jieruo Gu
Journal:  Rheumatol Int       Date:  2008-10-25       Impact factor: 2.631

6.  HLA B27 allele types in homogeneous groups of juvenile idiopathic arthritis patients in Latvia.

Authors:  Valda Stanevicha; Jelena Eglite; Dace Zavadska; Arturs Sochnevs; Arina Lazareva; Dinara Guseinova; Ruta Shantere; Dace Gardovska
Journal:  Pediatr Rheumatol Online J       Date:  2010-10-14       Impact factor: 3.054

7.  HLA-B, DR and DQ antigens polymorphism in Tunisian patients with ankylosing spondylitis (a case-control study).

Authors:  Mohamed Montacer Kchir; Wafa Hamdi; Lilia Laadhar; Samir Kochbati; Dhia Kaffel; Kaouthar Saadellaoui; Houria Lahmar; Mohamed Mehdi Ghannouchi; Dhouha Azzouz; Lilia Daoud; Abdelmajid Ben Hamida; Béchir Zouari; Mondher Zitouni; Sondes Makni
Journal:  Rheumatol Int       Date:  2009-08-05       Impact factor: 2.631

8.  Prevalence of HLA-B27 in Moroccan healthy subjects and patients with ankylosing spondylitis and mapping construction of several factors influencing AS diagnosis by using multiple correspondence analysis.

Authors:  Amal Akassou; Hanae Yacoubi; Afaf Jamil; Nadia Dakka; Saaïd Amzazi; Khalid Sadki; Redouane Niamane; Selma Elhassani; Youssef Bakri
Journal:  Rheumatol Int       Date:  2015-08-07       Impact factor: 2.631

9.  HLA-B*27 subtype specificity determines targeting and viral evolution of a hepatitis C virus-specific CD8+ T cell epitope.

Authors:  Katja Nitschke; Alejandro Barriga; Julia Schmidt; Jörg Timm; Sergei Viazov; Thomas Kuntzen; Arthur Y Kim; Georg M Lauer; Todd M Allen; Silvana Gaudieri; Andri Rauch; Christian M Lange; Christoph Sarrazin; Thomas Eiermann; John Sidney; Alessandro Sette; Robert Thimme; Daniel López; Christoph Neumann-Haefelin
Journal:  J Hepatol       Date:  2013-08-23       Impact factor: 25.083

10.  Associations between HLA-B27 subtypes and outcomes in Thai children with enthesitis-related arthritis.

Authors:  Soamarat Vilaiyuk; Butsabong Lerkvaleekul; Duangtawan Thammanichanond
Journal:  Clin Rheumatol       Date:  2021-08-06       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.